The Valley Desk

ArticleCurrent medical research and opinionPublished

Clinical outcomes with ciltacabtagene autoleucel among patients with relapsed/refractory multiple myeloma after four or more prior lines of therapy overall and among subgroups based on age, frailty, and CRAB symptoms

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Article
Venue
Current medical research and opinion
Published
Subject terms
Humans; Multiple Myeloma; Neoplasm Recurrence, Local; Treatment Outcome; Immunotherapy, Adoptive; Retrospective Studies; Age Factors; Aged; Aged, 80 and over; Middle Aged; Female; Male
PubMed ID
42057607
Added to directory
Source checked

Report a correction or request removal